Apoptosis: The suicide solution in cancer treatment and chemoprevention

Expert Opinion on Investigational Drugs

Volumn 15, Issue 6, 2006, Pages 575-577

  Sykiotis, Gerasimos P ^a   Papavassiliou, Athanasios G ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Apoptosis; Cancer chemoprevention; Cancer stem cells; Molecularly targeted agents

Indexed keywords

EPIDERMAL GROWTH FACTOR; IMATINIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; NOTCH RECEPTOR; POLYPHENOL DERIVATIVE; PROTEIN BCL 2; RETINOID; SONIC HEDGEHOG PROTEIN; TAMOXIFEN; WNT1 PROTEIN;

APOPTOSIS; BREAST CANCER; CANCER; CANCER CELL DESTRUCTION; CANCER COMBINATION CHEMOTHERAPY; CANCER RESEARCH; CANCER STEM CELL; CARCINOGENESIS; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL RENEWAL; CHRONIC MYELOID LEUKEMIA; CYTOSTASIS; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; DRUG TARGETING; EDITORIAL; HUMAN; MONOTHERAPY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRECANCER; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEOPLASMS; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR STEM CELLS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 33745236047     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.15.6.575     Document Type: Editorial

References (16)

1. HANAHAN D, WEINBERG RA. The hallmarks of cancer. Cell (2000) 100(l):57-70.
2. JOHNSTONE RW, RUEFLI AA, LOWE SW: Apoptosis: a link between cancer genetics and chemotherapy. Cell (2002) 108(2):153-164.
3. LOWE SW, LIN AW: Apoptosis in cancer. Carrinogenesis (2000) 21(3):485-495.
4. MAKING, DIVE C: Recent advances in understanding apoptosis: new therapeutic opportunities in cancer chemotherapy. Trends Mol. Med. (2003) 9(6):251-255.
5. HAMBURGER AW, SALMON SE: Primary bioassay of human tumor stem cells. Science (1977) 197(4302):461-463.
6. PARDAL R, CLARKE MF, MORRISON SJ: Applying the principles of stem-cell biology to cancer. Nat. Rev. Cancer (2003) 3(12):895-902.
7. BONNET D, DICK JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. (1997) 3(7):730-737.
8. AL-HAJJ M, WICHA MS, BENITO-HERNANDEZ, MORRISON SJ, CLARKE MF: Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA (2003) 100(7):3983-3988.
9. SINGH SK, HAWKINS C, CLARKE ID et al: Identification of human brain tumour initiating cells. Nature (2004) 432(7015):396-401.
10. HUFF CA, MATSUI W, SMITH BD, JONES RJ: The paradox of response and survival in cancer therapeutics. Blood (2006) 107(2):431-434.
11. MICHOR F, HUGHES TP, IWASA Y et al.: Dynamics of chronic myeloid leukaemia. Nature (2005) 435(7046):1267-1270.
12. GUZMAN ML, SWIDERSKI CF, HOWARD DS et al.: Preferential induction of apoptosis for primary human leukemic stem cells. Proc. Natl. Acad. Sci. USA (2002) 99(25):16220-16225.
13. SPORN MB: Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res. (1976) 36(7 Part 2):2699-2702.
14. SPORN MB, LIBY KT: Cancer chemoprevention: scientific promise, clinical uncertainty. Nat. Clin. Pract. Oncol. (2005) 2(10):518-525.
15. SUN SY, HAIL N Jr, LOTAN R: Apoptosis as a novel target for cancer chemoprevention. J. Natl. Cancer Inst. (2004) 96(9):662-672.
16. HAIL N Jr: Mitochondria: a novel target for the chemoprevention of cancer. Apoptosis (2005) 10(4):687-705.